蘆薈 Aloe Vera × 第二型糖尿病

結論:證據分歧

Three meta-analyses and one umbrella review (L2) consistently show oral aloe vera lowers HbA1c by roughly 0.

B 🟡 B 初步證據 證據分歧 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

Three meta-analyses and one umbrella review (L2) consistently show oral aloe vera lowers HbA1c by roughly 0.4-1.05% and reduces fasting glucose in type 2 diabetes and prediabetes, with the largest effect in poorly-controlled patients (baseline FBG >=200 mg/dL). However, every underlying trial is small (per-MA totals 89-470 patients), preparations and doses are non-standardized, heterogeneity is high, statistically significant publication bias was detected for fasting glucose, and several author teams explicitly call their own results inconclusive. Critically, the American Diabetes Association Standards of Care explicitly names aloe vera and states it is not recommended for glycemic benefits (L5e), and no other reviewed clinical body (Mayo, Cleveland, Harvard, NCCIH) endorses it for glycemic control. Examine's HbA1c grade B reflects the meta-analytic signal but, in my independent judgment, overweights a consistent pooled estimate built on low-quality trials with detected bias and contradicted by an explicit society non-recommendation. Weighing a real but fragile efficacy signal against trial-quality limitations and an explicit negative guideline, the totality of evidence supports grade C: a genuine effect may exist but is uncertain and not robust enough to recommend.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.56
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 證據分歧
信心度
70%
證據方向大致一致
證據層級
E2
多篇高品質統合分析(≥2 篇一致)

各層「支持此療效」的程度

分數越低=該層越不支持
L5 臨床機構權威立場
0.34
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.50
L3 機轉生理合理性
0.65
L2 PubMed原始文獻
0.70
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.557
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (4 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis
PMID: 27009750 2016 統合分析 n = 470
結論:In type 2 diabetes, aloe vera produced a marginal FPG reduction (MD -1.17 mmol/L, 95% CI -2.35 to 0.00, p=0.05) and a significant HbA1c reduction (MD -11 mmol/mol, 95% CI -19 to -2, p=0.01). In prediabetes, FPG fell significantly (MD -0.22 mmol/L, 95% CI -0.32 to -0.12, p<0.0001) but HbA1c did not (MD -2 mmol/mol, 95% CI -5 to 1).
🟠 品質有限 效應量:T2DM: HbA1c -11 mmol/mol (~ -1.0%); FPG -1.17 mmol/L (NS at p=0.05). Prediabetes: FPG -0.22 mmol/L; HbA1c NS
前往 PubMed
Reduction of Fasting Blood Glucose and Hemoglobin A1c Using Oral Aloe Vera: A Meta-Analysis
PMID: 27152917 2016 統合分析 n = 283
結論:Oral aloe vera significantly reduced FBG by 46.6 mg/dL (p<0.0001) and HbA1c by 1.05% (p=0.004). Subgroup with baseline FBG >=200 mg/dL showed a larger FBG reduction of 109.9 mg/dL (p<=0.0001). Publication bias was detected for FBG (p=0.010) but not HbA1c (p=0.602).
🟠 品質有限 效應量:FBG -46.6 mg/dL; HbA1c -1.05%
前往 PubMed
Efficacy of Aloe Vera Supplementation on Prediabetes and Early Non-Treated Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
PMID: 27347994 2016 統合分析 n = 415
結論:Aloe vera significantly reduced FBG (MD -30.05 mg/dL, 95% CI -54.87 to -5.23, p=0.02) and HbA1c (MD -0.41%, 95% CI -0.55 to -0.27, p<0.00001). It also lowered triglycerides (p=0.0001), total cholesterol (p<0.00001) and LDL-C (p<0.00001), and raised HDL-C (p=0.04). Authors call the results inconclusive given limited trial quality.
🟠 品質有限 效應量:FBG -30.05 mg/dL; HbA1c -0.41%
前往 PubMed
Effectiveness of aloe vera in patients with type 2 Diabetes Mellitus and pre-diabetes: An overview of systematic reviews
PMID: 34563809 2021 Umbrella Review
結論:Across 4 systematic reviews, in type 2 diabetes FBG decreased significantly (p<0.001) and HbA1c fell by approximately 0.95% (p=0.02); in prediabetes FBG improved (p=0.02), HbA1c fell ~0.31% (p=0.02), and triglycerides dropped ~5 mg/dL (p<0.001). Authors rated the body of evidence as moderate-to-high quality in favor of an effect.
🟠 品質有限 效應量:T2DM: HbA1c ~ -0.95%; Prediabetes: HbA1c ~ -0.31%
前往 PubMed

L4a US FDA
反對
The stimulant laxative ingredients aloe (including aloe extract and aloe flower extract) and cascara sagrada (including casanthranol, cascara fluidextract aromatic, cascara sagrada bark, cascara sagrada extract, and cascara sagrada fluidextract) in OTC drug products are not generally recognized as safe and effective or are misbranded. 來源↗
L4b EU EFSA
反對
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
謹慎
費拉蘆薈(Aloe vera)及好望角蘆薈(A. ferox)品種的葉子,須確實完全去皮後,才能加工使用,且蘆薈素(aloin)的含量不可以超過10 ppm。使用蘆薈葉作為原料之食品必須標示「孕婦忌食」警語字樣;產品檢具經檢驗機構檢驗所含「蘆薈素」含量低於1 ppm之分析證明者,得免標前述之警語。 來源↗
L4e WHO
謹慎
Aloe whole leaf extract is possibly carcinogenic to humans (Group 2B). [IARC Monographs Vol. 108, 2016 — sufficient evidence of carcinogenicity in experimental animals, inadequate evidence in humans] 來源↗

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
謹慎
Taking aloe gel by mouth while taking diabetes medicines might raise the risk of low blood sugar, called hypoglycemia. 來源↗
L5c Cleveland Clinic
中性
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
反對

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

台灣社群(PTT BeautySalon/regimen/FITNESS、Dcard、Mobile01)對「蘆薈」的討論幾乎全集中在蘆薈膠/蘆薈露的護膚、曬後鎮定用途,找不到鄉民將蘆薈用於控血糖或第二型糖尿病的真實實測心得。唯一將「蘆薈+血糖」連在一起的內容,多為商業健康媒體與 SEO 懶人包(如 healthyD、pure-au 假借『PTT推薦』、Bowtie)所製造的業配文,並非社群真實經驗。康健等衛教則反向提醒蘆薈素(aloin)過量恐致腹瀉與肝腎毒性。

💬社群實感

無共識(社群無蘆薈用於控血糖/糖尿病的真實實測心得;蘆薈討論幾乎全為護膚的蘆薈膠/蘆薈露,與血糖無關)

破解迷思 社群最常見的 3 個誤解
事實誤以為蘆薈能降血糖或輔助治療第二型糖尿病(此說多出自商業媒體/保健品業配,社群並無真實使用回饋支持)
事實把 SEO 懶人包標題的『PTT 推薦降血糖蘆薈』誤當成鄉民真實經驗(實為廣告農場假借 PTT 名號)
事實誤以為食用蘆薈是安全無虞的『天然食品』(忽略蘆薈素 aloin 過量的腹瀉與肝腎毒性風險)
🩹 社群通報的副作用
  • 腹痛、腹瀉(衛教轉述:蘆薈素 9~15 克即可能引發,非鄉民親身回報)
  • 蛋白尿、心跳過緩、肝腎毒性(衛教轉述,長期或過量食用)

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

Herb U Yogurt-aloe 蘆薈優格 TWD 55

代表來源 ↗
L10b · TFDA 法定身份 官方認定

蘆薈要當作食品原料,必須是費拉蘆薈(Aloe vera)及好望角蘆薈(A. ferox)品種的葉子,且須確實完全去皮後,才能加工使用;使用蘆薈葉作為原料之食品,蘆薈素(aloin)的含量不可以超過 10 ppm。

來源 ↗

  • 醫療營養治療與減重
  • 規律身體活動
  • Metformin(二甲雙胍)
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v26 engine_version: v1.0 claim_id: CLM-COND-type2-diabetes-INT-aloe-vera-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-type2-diabetes-INT-aloe-vera-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "蘆薈能改善第二型糖尿病",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 3,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟡 B 初步證據"
  }
}